Four Sigmatic Debuts The Last of Us Organic Ground Coffee, Infected with Focus & Energy

Four Sigmatic, the #1 functional coffee brand, announced the debut of The Last Of Us High Caffeine Organic Ground Coffee in collaboration with Sony Pictures Consumer Products. Four Sigmatic’s The Last of Us coffee is crafted with organic Arabica coffee, cordyceps (not mutated!) and lion’s mane mushrooms, vitamin B12, and coffee bean extract for infectious […]
CereVasc’s eShunt® System Gains FDA Breakthrough Designation
“The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces the potential safety and efficacy benefits that have already been observed with this minimally invasive, endovascular approach,” said Dan Levangie, Chairman & CEO of CereVasc, Inc. “We are encouraged and committed to making the eShunt System available to as many patients as possible living with this debilitating disease.”
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
“The EVSS represents a new paradigm in peripheral interventions,” said Christopher Haig, Co-Founder and CEO of Efemoral Medical. “It’s easy to deploy, has high radial strength, can be made in longer lengths, and offers the promise of durable outcomes without the need for a permanent implant.”
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair

Phasix™ ST Umbilical Hernia Patch leverages same surgical technique as permanent mesh procedures
Overcoming Taste and Texture Challenges In High-protein Snacks | By Jack Helm, Account Manager at Beverage, Bakery & Functional Snacks

Discover how to enhance taste and texture in high-protein snacks for better consumer appeal and satisfaction.
Boston Scientific Chief Financial Officer Dan Brennan to Retire | Jon Monson, SR VP, Investor Relations to succeed Brennan
Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
Navigating the Digital World: What Doctors Are Doing About Bad Reviews Online

Positive and negative online reviews can be managed in various ways. In this article, we’ll explore how doctors manage their online reputation and learn how to respond to negative patient reviews.
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory (“EMBL”), and its technology transfer arm EMBLEM.
Adventist HealthCare Emergency Departments Launch AI Initiative to Help Enhance Patient Safety and Care Efficiency
The software, KATE AI, is helping care teams ensure the safety and consistency of triage at Adventist HealthCare Shady Grove Medical Center, Adventist HealthCare White Oak Medical Center and Adventist HealthCare Fort Washington Medical Center. Emergency teams at the hospitals are using KATE AI to help verify care plans for patients who are at higher risk or have more complex conditions.
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDEÒ Drug Eluting Bioresorbable Scaffold
The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD, which according to the American Heart Association affects more than 200 million people globally, and 10 to 12 million in the U.S. older than the age of 40. The most common type of PAD affects the lower-extremity where blood flow is reduced to the legs and feet. Each year, approximately 150,000 leg amputations are performed in the U.S. alone.
Climate-Controlled Field Hospitals: Protecting Patients in Extreme Environments

Climate-controlled field hospitals have emerged as critical innovations in humanitarian response, military operations, and disaster relief efforts. These sophisticated temporary facilities enable healthcare delivery in environments where temperatures soar above 120°F or plummet below freezing, where sandstorms rage, or where monsoon rains threaten to wash away conventional tents.